相关实验视频

Updated: Jan 7, 2026

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

IL-1受体对抗作用通过RNF182驱动的MFN2不稳定和线粒体功能障碍减轻纤维化

Bo Yang¹, Qing Shao¹, Wei Wang¹

¹Department of Nephrology, Naval Medical Center of PLA, Naval Medical University, Shanghai, China.

Cell death discovery

|December 29, 2025

概括

再组合的人类IL-1受体抗剂 (rhIL-1Ra) 通过向IL-1R/RNF182/MFN2通路来对抗纤维化. 这种疗法保持了线粒体功能,减少了炎症,为慢性病 (CKD) 提供了潜在的治疗方法.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

纤维化驱动慢性病 (CKD) 的进展,具有有限的向治疗.
干白素-1 (IL-1) 介导的炎症和线粒体功能障碍与CKD有关,但它们的确切联系尚不清楚.

研究的目的:

在损伤模型中研究复合人类IL-1受体抗剂 (rhIL-1Ra) 的治疗潜力.
阐明连接IL-1信号传递,纤维化和线粒体平衡的分子机制.

主要方法:

使用急性 (UUO) 和慢性 (5/6Nx) 损伤的小鼠模型.
用TGF-β1刺激的细胞进行体外研究.
研究了E3无素化酶RNF182和线粒体蛋白MFN2.2.的作用.

主要成果:

在体内,rhIL-1Ra显著减少纤维化,炎症和改善功能.
rhIL-1Ra抑制了TGF-β1诱导的RNF182表达,防止了MFN2降解和随后的线粒体功能障碍.
通过rhIL-1Ra稳定MFN2,保持了线粒体呼吸,ATP生产,并减少了氧化应激.

结论:

一个新的IL-1R/RNF182/MFN2通路将炎症与脏中的线粒体和纤维病理联系起来.
RNF182被确定为线粒体功能障碍在纤维化中的关键调解者.
rhIL-1Ra通过向这种途径,证明了对CKD的治疗前景.

更多相关视频

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

相关概念视频

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...